Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Reduced Dose Zidovudine Compared With Standard Dose in Antiretroviral-naïve HIV Patients
NCT01540240Phase 3Unknown
- Start
- Aug 2011
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of zidovudine in human immunodeficiency virus infection (HIV). Status: unknown.
02
Drugs
zidovudine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT01540240.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01540240.